(Q46802987)

25 December 2017

title

CYP2D6 phenotype prediction from genotype: which system is the best? (English)

1 reference

25 December 2017

1 reference

J Kirchheiner

1

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

25 December 2017

Clinical Pharmacology & Therapeutics

published in

1 reference

25 December 2017

volume

83

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

225-227

1 reference

25 December 2017

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Nomenclature for human CYP2D6 alleles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100455

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100455

1 reference

25 December 2017

1 reference

25 December 2017